Onderneming Innocoll Holdings PLC Nasdaq
Aandelen
US45780Q1031
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
|
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kimball Hall
CEO | Chief Executive Officer | 58 | 26-01-23 |
Mark Uhle
DFI | Director of Finance/CFO | - | - |
Rebecca Bedno
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
David Arvan
PRN | Corporate Officer/Principal | - | - |
Robert Sklans
HRO | Human Resources Officer | - | - |
Comptroller/Controller/Auditor | - | 01-02-05 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 30 120 931 | 20 494 442 ( 68,04 %) | 25 000 ( 0,0830 %) | 68,04 % |
Bedrijfsgegevens
![Adres Innocoll Holdings PLC](https://cdn.zonebourse.com/static/address/17039500.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,32% | 819 mld. | |
-6,75% | 351 mld. | |
+13,56% | 329 mld. | |
+10,68% | 298 mld. | |
+16,57% | 242 mld. | |
+2,04% | 225 mld. | |
+13,31% | 217 mld. | |
+8,48% | 168 mld. | |
-2,81% | 158 mld. |